The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; EcoR1 Capital; FORMA Therapeutics; Genzyme; GlaxoSmithKline; Ions Pharmaceuticals; Janssen Biotech; Juno Therapeutics; Kite, a Gilead company; Legend Biotech; Molecular Partners; Sanofi; SERVIER; Takeda
Research Funding - BioTheryX
First-in-human phase I study of the novel CELMoD agent CC-92480 combined with dexamethasone (DEX) in patients (pts) with relapsed/refractory multiple myeloma (RRMM).
 
Paul G. Richardson
Consulting or Advisory Role - Celgene; Janssen; Jazz Pharmaceuticals; Karyopharm Therapeutics; Oncopeptides; Sanofi; Takeda
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); Oncopeptides (Inst); Takeda (Inst)
 
Annette J. Vangsted
Honoraria - Janssen
Consulting or Advisory Role - Oncopeptides; Sanofi; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Takeda
 
Karthik Ramasamy
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Adaptive Biotechnologies; Amgen; Bristol-Myers Squibb; Celgene; Janssen; Sanofi; Takeda
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene; Takeda
 
Suzanne Trudel
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Sanofi
Consulting or Advisory Role - Amgen; Celgene; GlaxoSmithKline
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Genentech; GlaxoSmithKline; Janssen
 
Joaquín Martínez
Consulting or Advisory Role - Adaptive Biotechnologies; Bristol-Myers Squibb; Gilead Sciences; Incyte; Janssen; Novartis; Roche
Speakers' Bureau - Adaptive Biotechnologies; Bristol-Myers Squibb; Gilead Sciences; Incyte; Janssen; Novartis; Roche
Research Funding - Bristol-Myers Squibb; Novartis
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Maria-Victoria Mateos
Honoraria - Abbvie/Genentech; Adaptive Biotechnologies; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; Pharmamar-zeltia; Takeda
 
Paula Rodríguez Otero
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen; Kite, a Gilead company; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene
 
Sagar Lonial
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Juno Therapeutics; Merck; Novartis; Takeda
Research Funding - Bristol-Myers Squibb; Celgene; Takeda
 
Rakesh Popat
Honoraria - Celgene; GlaxoSmithKline; Janssen; Takeda
Consulting or Advisory Role - Abbvie; Celgene; GlaxoSmithKline; Takeda
Research Funding - Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; Janssen; Takeda
 
Albert Oriol
Consulting or Advisory Role - Amgen; Celgene; Janssen
Speakers' Bureau - Amgen; Celgene
 
Chatchada Karanes
No Relationships to Disclose
 
Robert Z. Orlowski
No Relationships to Disclose
 
Jesus G. Berdeja
Consulting or Advisory Role - Amgen (Inst); BioClinica (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); crispr therapeutics (Inst); Janssen (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Kite, a Gilead company (Inst); Legend Biotech (Inst); prothena (Inst); SERVIER (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Acetylon Pharmaceuticals (Inst); Amgen (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Constellation Pharmaceuticals (Inst); CURIS (Inst); Genentech/Roche (Inst); Glenmark (Inst); Janssen (Inst); Kesios Therapuetics (Inst); Lilly (Inst); Novartis (Inst); poseida therapeutics (Inst); Sanofi (Inst); Takeda (Inst); Teva (Inst); Vivolux (Inst)
 
Lilly Wong
Employment - Bristol-Myers Squibb; Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb; Celgene
 
Chenyang Shi
Employment - Bristol-Myers Squibb; Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene
 
Manisha Lamba
Employment - Bristol-Myers Squibb; Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene; Pfizer
 
Evelyn Barnett
Employment - Bristol-Myers Squibb; Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene
 
Daniel W. Pierce
Employment - Agilent; Bristol-Myers Squibb; Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb; Celgene
 
Michael Pourdehnad
Employment - Bristol-Myers Squibb; Celgene
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene
Patents, Royalties, Other Intellectual Property - Bristol-Myers Squibb; Celgene
 
Nizar J. Bahlis
Honoraria - Abbvie; Amgen; Celgene; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Research Funding - Celgene (Inst); Janssen (Inst)